Chronic migraines are a real pain, literally. They can last for weeks or even months. People who suffer from them often try different treatments to find relief. One study looked at combining two treatments: atogepant and onabotulinumtoxinA. The goal was to see if this combo could help control chroni
Migraines are a big deal, affecting around 14. 4% of people worldwide. This means nearly one in seven individuals is dealing with this painful condition. The goal was to understand who gets migraines and how it impacts their healthcare needs. First, let's talk about the numbers. Migraines are more
Migraine sufferers often find relief with medications like valproate, topiramate, metoprolol, timolol, or propranolol. These are commonly prescribed as first-line treatments. But do these meds also lower the risk of ischemic stroke? That's what researchers wanted to find out. They dug into two mass
Migraines aren't just headaches; they're a complex neurological condition. Researchers have been using fMRI scans to learn more about what's happening in the brain during a migraine. Studies have shown different things. Looming limitations come from the mixed bag of variables and m
What if you lived with a condition that could hit anytime, often leaving you powerless? Chronic migraines are common and can severely affect your life. Each month, it can strike for 10 days. People who suffer from this usually seek medical help. One approach to manage chro
Scientists have found a new way to use information from nuclear magnetic resonance (NMR) experiments to help understand the shapes of special proteins. These proteins, called multistate proteins, intrinsically disordered proteins (IDPs), and proteins with intrinsically disordered regions (IDRs), are
Migraines – oh, the dreaded headaches! They can really mess with your life. You might have heard that fatty acid supplements could help. Some studies and reviews say they do, but others aren't so sure. Let's dive into what's been found so far. Migraines are common, affecting many people worldwide.
Meet rimegepant, a new drug that blocks certain signals in your brain to stop migraines. It's been tested in labs and found to work, but what about in the real world? That's what the GAINER study set out to find. This study, happening in multiple places, looked at how well rimegepant works and how t
You know how sometimes we struggle to understand the tiny details in documents? Think of a chart with lots of numbers or a PDF with complex texts. That's where multimodal large language models (MLLMs) come in. They're supposed to help us make sense of these things, but they've been falling short, es
Ever wondered how potassium affects rice? Researchers recently explored this question by testing different amounts of potassium fertilizer on two kinds of rice, Xiadao No. 1 and Shenliangyou 5814, across two years. They used five different rates: 0, 60, 120, 180, and 240 kg of potassium oxide per he
